Tianshi David Wu1, Emily P Brigham1, Corinne A Keet2, Todd T Brown3, Nadia N Hansel1, Meredith C McCormack4. 1. Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Md. 2. Division of Pediatric Allergy and Immunology, School of Medicine, Johns Hopkins University, Baltimore, Md. 3. Division of Endocrinology, Diabetes, and Metabolism, School of Medicine, Johns Hopkins University, Baltimore, Md. 4. Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Md. Electronic address: mmccor16@jhmi.edu.
Abstract
BACKGROUND: Metabolic dysfunction may contribute to worsened asthma in obesity. The relationship between prediabetes and diabetes, metabolic conditions more common in obesity, and asthma outcomes is not well characterized. OBJECTIVE: We sought to determine the association between prediabetes/diabetes and asthma exacerbations in an obese asthma cohort. METHODS: A retrospective cohort of US obese adults with asthma, aged 18-64, was created from a claims-based health services database spanning 2010 to 2015. Individuals with a hemoglobin A1c (HbA1c) measurement were identified, categorized as within normal (<5.6%), prediabetes (5.7% to 6.4%), and diabetes (≥6.5%) ranges. Exacerbations, defined as asthma-related hospitalization, emergency department visit, or corticosteroid prescription ±14 days of an asthma-related outpatient visit, were ascertained. Associations were fit with zero-inflated negative binomial models, adjusted for age, sex, region, smoking, medication use, and comorbidities. RESULTS: A total of 5722 individuals were identified. Higher HgbA1c was associated with higher asthma exacerbation rates. In the fully adjusted model, compared with individuals with normal HbA1c, those in the prediabetes range had a 27% higher rate (95% confidence interval [CI], 5% to 52%), and those in the diabetes range had a 33% higher rate (95% CI, 2% to 73%). CONCLUSIONS: Prediabetes and diabetes were associated with higher rates of asthma exacerbation among obese adults with asthma. Results support evidence that insulin resistance and metabolic syndrome, metabolic features common in prediabetes/diabetes, can influence asthma morbidity.
BACKGROUND:Metabolic dysfunction may contribute to worsened asthma in obesity. The relationship between prediabetes and diabetes, metabolic conditions more common in obesity, and asthma outcomes is not well characterized. OBJECTIVE: We sought to determine the association between prediabetes/diabetes and asthma exacerbations in an obese asthma cohort. METHODS: A retrospective cohort of US obese adults with asthma, aged 18-64, was created from a claims-based health services database spanning 2010 to 2015. Individuals with a hemoglobin A1c (HbA1c) measurement were identified, categorized as within normal (<5.6%), prediabetes (5.7% to 6.4%), and diabetes (≥6.5%) ranges. Exacerbations, defined as asthma-related hospitalization, emergency department visit, or corticosteroid prescription ±14 days of an asthma-related outpatient visit, were ascertained. Associations were fit with zero-inflated negative binomial models, adjusted for age, sex, region, smoking, medication use, and comorbidities. RESULTS: A total of 5722 individuals were identified. Higher HgbA1c was associated with higher asthma exacerbation rates. In the fully adjusted model, compared with individuals with normal HbA1c, those in the prediabetes range had a 27% higher rate (95% confidence interval [CI], 5% to 52%), and those in the diabetes range had a 33% higher rate (95% CI, 2% to 73%). CONCLUSIONS:Prediabetes and diabetes were associated with higher rates of asthma exacerbation among obese adults with asthma. Results support evidence that insulin resistance and metabolic syndrome, metabolic features common in prediabetes/diabetes, can influence asthma morbidity.
Authors: Anne Fuhlbrigge; David Peden; Andrea J Apter; Homer A Boushey; Carlos A Camargo; James Gern; Peter W Heymann; Fernando D Martinez; David Mauger; William G Teague; Carol Blaisdell Journal: J Allergy Clin Immunol Date: 2012-03 Impact factor: 10.793
Authors: Eva Lessmann; Gordon Grochowy; Lars Weingarten; Torsten Giesemann; Klaus Aktories; Michael Leitges; Gerald Krystal; Michael Huber Journal: Exp Hematol Date: 2006-11 Impact factor: 3.084
Authors: Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali Journal: Med Care Date: 2005-11 Impact factor: 2.983
Authors: Carlos Lorenzo; Lynne E Wagenknecht; Anthony J G Hanley; Marian J Rewers; Andrew J Karter; Steven M Haffner Journal: Diabetes Care Date: 2010-06-23 Impact factor: 19.112
Authors: Natalia Weare-Regales; Sergio E Chiarella; Juan Carlos Cardet; Y S Prakash; Richard F Lockey Journal: J Allergy Clin Immunol Pract Date: 2022-04-15
Authors: Peng Zhang; Rocio Lopez; Amy H Attaway; Steve N Georas; Sumita B Khatri; Simon Abi-Saleh; Joe G Zein Journal: J Allergy Clin Immunol Pract Date: 2020-11-09
Authors: Antonio Barajas-Martínez; Elizabeth Ibarra-Coronado; Martha Patricia Sierra-Vargas; Ivette Cruz-Bautista; Paloma Almeda-Valdes; Carlos A Aguilar-Salinas; Ruben Fossion; Christopher R Stephens; Claudia Vargas-Domínguez; Octavio Gamaliel Atzatzi-Aguilar; Yazmín Debray-García; Rogelio García-Torrentera; Karen Bobadilla; María Augusta Naranjo Meneses; Dulce Abril Mena Orozco; César Ernesto Lam-Chung; Vania Martínez Garcés; Octavio A Lecona; Arlex O Marín-García; Alejandro Frank; Ana Leonor Rivera Journal: Front Physiol Date: 2021-01-12 Impact factor: 4.566
Authors: Dinah Foer; Patrick E Beeler; Jing Cui; Elizabeth W Karlson; David W Bates; Katherine N Cahill Journal: Am J Respir Crit Care Med Date: 2021-04-01 Impact factor: 21.405